ArticleThe Lancet. Infectious diseases2025

Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.

Ahmed Babiker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.